Our Team
ImmuONE is only as good as the people who run it! At the heart of ImmuONE is our unique team. We are alveolar
experts that think innovatively, identify problems and come up with creative solutions. We’re laser focused on helping our clients to reach their goals and use our in vitro lung models to address research questions and to conduct top-of-the-range human-relevant risk assessments. Here’s a little bit about us:
Board of Directors
Dr Abigail Martin
Cofounder & Chief Commercial Officer-
Abigail leads our commercial strategy, revenue growth, industry partnerships and product positioning, championing standardised human‑relevant in vitro alternatives to animal testing. A scientist turned biotech entrepreneur, she cofounded the university spin‑out ImmuONE in 2019, secured early Innovate UK and seed funding, and scaled the company through the successful launch of multiple human lung and immune in vitro products.
Prof Victoria Hutter
CEO and CoFounder
Victoria drives our scientific and commercial strategy, positioning ImmuONE as a sector leader, leading the New Approach Methodologies (NAMs) agenda, and pushing for global uptake and regulatory acceptance of assays for respiratory toxicology. Trained as a pharmacist, her experience spans academia and the pharmaceutical industry, with a focus on pulmonary drug delivery, advanced in vitro cell culture models and assay development. She has a strong focus on solving industry needs through the creation of more predictive testing systems.
David Baker
Investor director
David represents Mercia Ventures on our board, working with the founders to help define strategy, raise investment and scale the company. He invests in technology companies from Seed to Series A across several sectors, working with ambitious and driven founders. He previously worked in corporate finance advisory, specialising in sell-side M&A and raising investment for growth.
Dr Richard Weaver
Director
Drawing on his experience founding, leading, growing and selling the UK DMPK CRO XenoGesis, Richard provides strategic, scientific and commercial advice to drive our growth and success. He has nearly three decades of experience in DMPK and Drug Discovery at AZ and CROs, most recently founding Drug Discovery Solutions Limited, and holds NED positions in several UK CROs.
Jon Green
Chief Operating Officer
Jon oversees our day-to-day operations, translating business strategy into pragmatic plans and ensuring cross functional alignment to drive operational efficiency and scalable growth. A scientist by training, he has extensive expertise in strategy and scientific operations, having led large-scale laboratory facilities, complex capital projects, and multi-disciplinary teams within global organisations.
Dr Ewelina Hoffman
Head of Science
Ewelina is responsible for setting and delivering our scientific strategy, ensuring the quality, credibility, and impact of research outputs, and translating scientific innovation into reproducible, commercially and scientifically meaningful outcomes. She brings over 15 years of experience in in vitro biological modelling and high‑content imaging-based assay development, specialising in advanced respiratory disease and toxicity models, together with a passion for scientific innovation and the advancement of animal‑free research.
Dr Vinit Pereira
Head of Business Development
Vinit leads the development of our business growth and commercial frameworks to position the company as the benchmark standard for human‑relevant inhalation toxicology. With more than 11 years’ experience, including cross‑functional leadership, business analytics, marketing, and strategic planning, he is dedicated to building impactful collaborations that accelerate innovation, strengthen our portfolio, and advance solutions for areas of significant unmet need.
Nilab Haydare
Head of events & marketing
As Head of Marketing and Events at ImmuONE, Nilab delivers strategic event planning, marketing, and scientific communications to raise brand visibility, foster industry relationships and support commercial growth. With a BSc in Pharmaceutical Science and hands‑on experience spanning in vitro research and business development, Nilab bring a strong scientific foundation and a passion for translating complex science into impactful marketing and event activity.
Josephine Joel
Principal Scientist
Jo co-ordinates the expansion of commercial and internal R&D in vitro projects as Study Lead, liaising with clients to ensure all deliverables are executed according to timeframes. She has 25 years of industry experience across both small biotech and large pharma, covering translational biology, AAV gene therapy, and drug development.
Dr Ginez Gonzalez
Senior Scientist
Ginez supports our experimental work including the design, execution and interpretation of results for internal and client based projects. He brings more than 10 years of combined experience in industry and academia, including cell line and primary cell cultures, molecular biology, high-content microscopy, and drug discovery.
Dr Rhamiya Mahendran
Commercial Lead
Rhamiya supports business development and scientific activities at ImmuONE, including planning and hosting webinars to engage external audiences. With over 11 years of experience in toxicology and applied research, and a background shaped by her PhD studies, she has built a strong interest in applying scientific innovation within industry.
Elinda Zeqiri
Senior Scientist / PhD
Elinda supports our experimental work through the design, execution, and interpretation of results for both internal and client-based projects, with a focus on cell culture–based studies to generate data and contribute to experimental workflows. She has over five years of combined academic and industry experience in cell culture, toxicology, and applied research, with a strong interest in translating scientific innovation into industry.
Molly Rankine
Laboratory Technician
Molly supports our laboratory operations by working closely with the cell culture team to support both commercial and R&D projects and contributing to experimental workflows. She conducts experimental assays, generating high-quality data and contributing to robust data analysis. Molly plays a key role in ensuring the smooth operation of laboratory activities.
Yemi Ayeni
Executive Assistant & Office Manager
Yemi supports our leadership and the wider ImmuONE team by delivering high‑level executive assistance, office operations management, and seamless stakeholder coordination across the organisation.
Kate FLanagan
Business Finance Manager
Kate oversees our finance function and supports the wider business in financial matters. She brings more than 30 years of experience within finance, starting in accountancy practice before moving into the commercial world.